英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Faropenem finished product impurity 4 |
法羅培南成品雜質(zhì)4 |
613670-77-2 |
詳細(xì)
|
Lorazepam EP Impurity C |
勞拉西泮EP雜質(zhì)C |
2955-37-5 |
詳細(xì)
|
Sodium 7-hydroxy-1,3,6-naphthalene trisulfonate |
7-羥基-1,3,6-萘三磺酸鈉 |
53683-45-7 |
詳細(xì)
|
Disodium 7-hydroxy-1,3-naphthalenedisulfonate |
7-羥基-1,3-萘二磺酸二鈉 |
842-19-3 |
詳細(xì)
|
Impurity I (isoproterenol) |
雜質(zhì)I (異丙腎上腺素) |
28148-80-3 |
詳細(xì)
|
Impurity J |
雜質(zhì)J |
767223-03-0 |
詳細(xì)
|
Impurities of allopurinol 25 |
別嘌醇雜質(zhì)25 |
30129-57-8 |
詳細(xì)
|
Benidipine hydrochloride impurity 17 |
鹽酸貝尼地平雜質(zhì)17 |
2418591-38-3 |
詳細(xì)
|
Ornidazole Impurity 22 |
奧硝唑雜質(zhì)22 |
74550-92-8 |
詳細(xì)
|
Succinyl Monocholine Chloride Impurity 01 |
琥拍酰氯膽堿雜質(zhì)01 |
5297-17-6 |
詳細(xì)
|
Nifedipine Impurity 13 |
硝苯地平雜質(zhì)13 |
88434-69-9 |
詳細(xì)
|
9-cis,13-cis-Retinol 15-Acetate |
維生素A棕櫚酸酯雜質(zhì)08 |
29444-27-7 |
詳細(xì)
|
Ziprasidone Impurity H |
齊拉西酮雜質(zhì)H |
884305-07-1 |
詳細(xì)
|
Pyrpidil Impurity 6 |
吡貝地爾雜質(zhì)6 |
20850-43-5 |
詳細(xì)
|
Minocycline E Impurity B |
米諾環(huán)素E雜質(zhì)B |
808-26-4 |
詳細(xì)
|
Baloxavir Marboxil Impurity 01 |
巴洛沙韋酯雜質(zhì)01 |
1985605-59-1 |
詳細(xì)
|
Cilnidipine Impurity 5 |
西尼地平雜質(zhì)5 |
74936-76-8 |
詳細(xì)
|
Entacapone Impurity K |
恩他卡朋雜質(zhì)K |
1217439-96-7 |
詳細(xì)
|
4H-Pyran-4-one, 2-ethyl-3-(phenylmethoxy)- |
去鐵酮雜質(zhì)03 |
111782-87-7 |
詳細(xì)
|
Nicardipine Impurity 11 |
尼卡地平雜質(zhì)11 |
115972-93-5 |
詳細(xì)
|
3,5-DINITROBENZALDEHYDE |
3,5-硝基苯甲醛 |
14193-18-1 |
詳細(xì)
|
3-Pyridinecarboxamide, N,N-diethyl-1,6-dihydro-6-oxo- |
尼可剎米雜質(zhì)17 |
366448-31-9 |
詳細(xì)
|
Nicardipine Impurity 02 |
尼卡地平雜質(zhì)02 |
54827-65-0 |
詳細(xì)
|
Alogliptin Impurity 02 |
阿格列汀雜質(zhì)02 |
22115-41-9 |
詳細(xì)
|
Adrenaline hydrochloride impurity G |
鹽酸腎上腺素雜質(zhì)G |
13062-58-3 |
詳細(xì)
|
Azilsartan Impurity 13 |
阿齊沙坦雜質(zhì)13 |
136258-69-3 |
詳細(xì)
|
1,3-Di(pyridin-4-yl)urea |
1.3-二(吡定-4-基)脲 |
39642-87-0 |
詳細(xì)
|
Impurity M of norepinephrine tartrate |
重酒石酸去甲腎上腺素雜質(zhì) M |
24159-36-2 |
詳細(xì)
|
Mizolastine Impurity 28 |
咪唑斯汀雜質(zhì)28 |
935860-13-2 |
詳細(xì)
|
Vonoprazan Impurity 42 |
沃諾拉贊雜質(zhì)42 |
2416241-98-8 |
詳細(xì)
|
N,N'-dimethylnitrosourea |
1,3-二甲基-1-亞硝基脲 |
13256-32-1 |
詳細(xì)
|
Irsogladine Impurity 04 |
伊索拉定雜質(zhì)04 |
4514-54-9 |
詳細(xì)
|
Iron ketone impurity 09 |
去鐵酮雜質(zhì)09 |
644-46-2 |
詳細(xì)
|
2-N,2-N,5-N,5-N-tetraethylpyridine-2,5-dicarboxamide |
尼可剎米雜質(zhì)15 |
5217-97-0 |
詳細(xì)
|
Baloxavir Marboxil Impurity 29 |
巴洛沙韋酯雜質(zhì)29 |
2136287-61-9 |
詳細(xì)
|
Azilsartan Impurity 27 |
阿齊沙坦雜質(zhì)27 |
139481-44-0 |
詳細(xì)
|
Lodoxamide Tromethamine |
洛度沙胺氨丁三醇 |
63610-09-3 |
詳細(xì)
|
Cisatracurium Besylate EP Impurity A(INC) |
苯磺順阿曲庫銨雜質(zhì)11(INC) |
1075727-06-8 |
詳細(xì)
|
Letomovir Impurity 14(SM1) |
來特莫韋雜質(zhì)14(SM1) |
917389-26-5 |
詳細(xì)
|
Ziprasidone Impurity N |
齊拉西酮雜質(zhì)N |
188797-77-5 |
詳細(xì)
|
Pyrpidil impurity 5 |
吡貝地爾雜質(zhì)5 |
121-44-8 |
詳細(xì)
|
Entacapone Impurity A |
恩他卡朋雜質(zhì)A |
130929-57-6 |
詳細(xì)
|
Nimodipine Impurity 20 |
尼莫地平雜質(zhì)20 |
74936-69-9 |
詳細(xì)
|
6,6'-DIHYDROXY-5,5'-DIMETHOXY-[1,1'-BIPHENYL]-3,3'-DICARBOXALDEHYDE |
去氫-二香蘭素 |
2092-49-1 |
詳細(xì)
|
Indolecyanine green intermediate 1 |
吲哚菁綠中間體1 |
63149-24-6 |
詳細(xì)
|
Tedizolid Impurity 13 |
特地唑胺雜質(zhì)13 |
97483-77-7 |
詳細(xì)
|
Alogliptin Impurity 20 |
阿格列汀雜質(zhì)20 |
2089611-85-6 |
詳細(xì)
|
Letomovir impurity 05(SM1-D) |
來特莫韋雜質(zhì)05(SM1-D) |
1791412-01-5 |
詳細(xì)
|
Azilsartan Impurity P |
阿齊沙坦雜質(zhì)P |
1675221-59-6 |
詳細(xì)
|
Ivan Kase Impurity 05 |
伊萬卡塞雜質(zhì)05 |
52417-52-4 |
詳細(xì)
|
Ziprasidone Impurity 15(INT2-D) |
齊拉西酮雜質(zhì)15(INT2-D) |
884305-06-0 |
詳細(xì)
|
Ziprasidone Impurity M |
齊拉西酮雜質(zhì)M |
188797-80-0 |
詳細(xì)
|
Lodoxamide lmpurity 01 |
洛度沙胺雜質(zhì)01 |
53882-12-5 |
詳細(xì)
|
Phenylephrine impurity E |
苯腎上腺素雜質(zhì)E |
71786-67-9 |
詳細(xì)
|
Levomevir Impurity 02 (SM1-A) |
來特莫韋雜質(zhì)02(SM1-A) |
65896-11-9 |
詳細(xì)
|
1-(Pyridin-4-yl)urea |
(吡啶-4-基)脲 |
13262-38-9 |
詳細(xì)
|
Nicardipine Impurity 05 |
尼卡地平雜質(zhì)05 |
58368-87-9 |
詳細(xì)
|
Lornoxicam impurity 09 |
氯諾昔康雜質(zhì)09 |
1017791-22-8 |
詳細(xì)
|
Nicardipine Impurity 08 |
尼卡地平雜質(zhì)08 |
54527-73-0 |
詳細(xì)
|
Nicardipine Impurity 09 |
尼卡地平雜質(zhì)09 |
69441-29-8 |
詳細(xì)
|
dimethyl 4-hydroxy-4-methyl-2-(3-nitrophenyl)-6-oxocyclohexane-1,3-dicarboxylate |
鹽酸貝尼地平雜質(zhì)18 |
142592-09-4 |
詳細(xì)
|
Iron ketone impurity 12 (impurity F) |
去鐵酮雜質(zhì)12(雜質(zhì)F) |
50700-61-3 |
詳細(xì)
|
Impurity of nifedipine |
非洛地平雜質(zhì) |
626-34-6 |
詳細(xì)
|
3-(1,4-Cyclohexadien-1-yl)-1-p |
3-(1,4-環(huán)己二烯基)-1-丙醇 |
87151-66-4 |
詳細(xì)
|
Azilsartan Impurity 08 |
阿齊沙坦雜質(zhì)08 |
147404-12-4 |
詳細(xì)
|
Benzenepropanamine, N,α-dimethyl-, hydrochloride (1:1) |
拉貝洛爾雜質(zhì)40 |
1081527-67-4 |
詳細(xì)
|
Mianserin Impurity 18 |
米安色林雜質(zhì)18 |
2705077-27-4 |
詳細(xì)
|
Indolecyanine green intermediate 2 |
吲哚菁綠中間體2 |
63450-66-8 |
詳細(xì)
|
1,2-Bis(4-pyridyl)hydrazine,2-Bis(4-pyridyl)hydrazine |
|
19808-51-6 |
詳細(xì)
|
2-(Methylamino)-N-[6-(trifluoromethoxy)-2-benzothiazolyl]acetamide |
利魯唑雜質(zhì)25 |
1619968-52-3 |
詳細(xì)
|
Lacidipine EP Impurity B |
拉西地平EP雜質(zhì)B |
130996-24-6 |
詳細(xì)
|
Drotaverine Impurity 19 |
屈他維林雜質(zhì)19 |
854869-48-0 |
詳細(xì)
|
Irsogladine Impurity 10 |
伊索拉定雜質(zhì)10 |
29366-77-6 |
詳細(xì)
|
1-Ethyl-3-hydroxy-2-methyl-4(1H)-pyridinone |
去鐵酮雜質(zhì)01 |
30652-12-1 |
詳細(xì)
|
Isoproterenol Impurity B |
異丙腎上腺素雜質(zhì)B |
3506-32-9 |
詳細(xì)
|
Nicardipine Impurity 04 |
尼卡地平雜質(zhì)04 |
64603-72-1 |
詳細(xì)
|
3-hydroxy-1-isopropyl-2-methylpyridin-4(1H)-one |
去鐵酮雜質(zhì)11 (雜質(zhì)K) |
30652-14-3 |
詳細(xì)
|
Benidipine hydrochloride impurity 20 |
鹽酸貝尼地平雜質(zhì)20 |
89080-61-5 |
詳細(xì)
|
Butanoic acid, 2-[(4-nitrophenyl)methylene]-3-oxo-, methyl ester, (2Z)- |
樂卡地平雜質(zhì)04 |
184681-54-7 |
詳細(xì)
|
Labetalol Impurity 22 |
拉貝洛爾雜質(zhì) 22 |
723733-75-3 |
詳細(xì)
|
Nicardipine Impurity 07 |
尼卡地平雜質(zhì)07 |
132100-30-2 |
詳細(xì)
|
Labetalol Impurity 39 |
拉貝洛爾雜質(zhì)39 |
2820170-74-7 |
詳細(xì)
|
5,6 Epoxy Vitamin A Palmitate |
維生素A棕櫚酸酯雜質(zhì)01 |
3012-64-4 |
詳細(xì)
|
Liraglutide impurity |
利魯唑雜質(zhì) |
1188047-00-8 |
詳細(xì)
|
5-Hydroxy-1,2-dimethyl-4(1H)-pyridinone |
去鐵酮雜質(zhì)10(雜質(zhì)R) |
60403-96-5 |
詳細(xì)
|
Ziprasidone Impurity 6 |
齊拉西酮雜質(zhì)21 |
1154908-21-0 |
詳細(xì)
|
Bevanolol impurity 05 |
貝凡洛爾雜質(zhì)05(定入質(zhì)量標(biāo)準(zhǔn)) |
747351-40-2 |
詳細(xì)
|
Probuco Impurities 01 |
普羅布考雜質(zhì)01 |
3597-71-9 |
詳細(xì)
|
Irsogladine Impurity 11 |
伊索拉定雜質(zhì)11 |
57381-53-0 |
詳細(xì)
|
Piribedil Impurity 12 |
吡貝地爾雜質(zhì)12 |
42123-22-8 |
詳細(xì)
|
Ziprasidone Impurity 20(SM3-E) |
齊拉西酮雜質(zhì)20(SM3-E) |
131779-59-4 |
詳細(xì)
|
6-(TRIFLUOROMETHOXY)-2(3H)-BENZOTHIAZOLONE HYDRAZONE |
利魯唑雜質(zhì)15 |
133840-98-9 |
詳細(xì)
|
Chlorhexidine Impurity 16 (INT3-A) |
氯諾昔康雜質(zhì)16(INT3-A) |
72957-44-1 |
詳細(xì)
|
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-[2-[(3,3-diphenylpropyl)methylamino]-1,1-dimethylethyl] 5-(1-methylethyl) ester, hydrochloride (1:1) |
樂卡地平雜質(zhì)02 |
210579-72-9 |
詳細(xì)
|
Nicotinamide Impurities 13 |
尼可剎米雜質(zhì)13 |
940-06-7 |
詳細(xì)
|
|
去鐵酮雜質(zhì)07 |
3023653-95-1 |
詳細(xì)
|
Lorazepam EP Impurity D |
勞拉西泮EP雜質(zhì)D |
54699-91-1 |
詳細(xì)
|
Glucose acid impurity 12 |
葡萄糖酸雜質(zhì)12 |
2348-31-4 |
詳細(xì)
|
Vancomycin Impurity M |
萬古霉素雜質(zhì)M |
250273-66-6 |
詳細(xì)
|
Lorazepam USP Impurity D |
勞拉西泮USP雜質(zhì)D |
54643-79-7 |
詳細(xì)
|